Enveda
Last verified 2026-05-06. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $350.0Mattributed |
|---|---|
| Latest round | series-d+, $150.0M, 2025-09-15attributed |
| Founded | 2019 |
| Headquarters | Boulder, USA |
| Industry | bio |
| Stage | series-b+ |
| Website | enveda.com |
Enveda is a Boulder biotech mining plant chemistry with mass spectrometry and AI to find oral small-molecule drugs. It targets immunology, obesity, and neurosensory indications where natural products historically failed for cost. Pipeline includes ENV-294 in Phase 2a for atopic dermatitis and ENV-308 in Phase 1 for weight maintenance.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-09-15 | series-d+ | $150.0M | undisclosed |
Detected tech stack
Cloudflare, WordPress, Google Tag Manager, Fathom, Site Kit 1.179.0, Slick, Popper, Drift, HubSpot, Cloudflare Bot Management, WP Engine, PHP
Provenance
| Fact | Status | Basis |
|---|---|---|
| Series D+, $150.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Total raised $350.0M | attributed | techcrunch named as publisher. No document URL on file. |
| Company existence | self-reported | enveda.com, read 2026-05-06 |
| Description | self-reported | enveda.com, read 2026-05-06 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.